The Basic Principles Of Thromboxane B2
Contraindicated (one)bortezomib will raise the degree or result of mavacamten by influencing hepatic enzyme CYP2C19 metabolism. Contraindicated. Solid or reasonable CYP2C19 inhibitors may possibly enhance mavacamten systemic exposure, resulting in heart failure as a result of systolic dysfunction.